39
INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224- 241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259) Avian Flu SARS Fungal Diseases - Chapter 18

INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Embed Size (px)

Citation preview

Page 1: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

INFECTIOUS PULMONARY DISEASES

Module HPneumonia -Chapter 15 (pp. 224-241)

Lung Abscess - Chapter 16 (pp. 242-249)Tuberculosis – Chapter 17 (pp. 250-259)

Avian FluSARS

Fungal Diseases - Chapter 18 (pp. 260-271)

Page 2: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Pneumonia• Inflammatory Process

• Gas Exchange areas of the lung.

• Alveolar Consolidation• Alveoli become filled with fluid, RBC, WBC and

macrophages.

• 2 million cases/year with 40,000 to 70,000 deaths.• 6th leading cause of death• “Old Man’s Friend”

Page 3: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)
Page 4: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Etiology

• Bacteria

• Viruses

• Fungi

• Rickettsia

• Protozoa

• Anaerobic organisms

Page 5: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Pneumonia vs. Pneumonitis

• Pneumonia is an infection with an inflammatory response and consolidation of the lung parenchyma.

• Pneumonitis is an inflammatory response due to a non-infectious agent.

Page 6: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Aspiration Pneumonitis

• Etiology• Strokes• Neuromuscular disease• Decreased level of consciousness

• Alcoholics• Drug Abuse• Head Injury

• Chemical (Mendelson’s Syndrome)• Inhalation of gastric acid

Page 7: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Types of Pneumonia• Lobar Pneumonia

• Involves the entire lobe

• Segmental (Lobular)• Bronchopneumonia

• Alveoli contiguous to an bronchi

• Interstitial Tissues

• Double Pneumonia: Both lungs• Walking Pneumonia: Mild form of pneumonia

• Mycoplasma Pneumoniae

• Necrotizing Pneumonia

Page 8: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

At Risk Patients• Elderly• Chronic Disease

• Diabetes, Renal Disease, Alcoholics

• Immunosuppressed Patients• Cancer patients• AIDS• Transplant patients• Malnutrition• Patients on steroids

• Burn victims• Leukemia• Drug abuse

Page 9: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Classification of Pneumonia

• Nosocomial • Diagnosed 48 hours after hospital admission.• Ventilator Associated Pneumonia (VAP) is a

subset of nosocomial infections.

• Community –Acquired Pneumonia • Outside a health care setting.

Page 10: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Pneumonia during Mechanical Ventilation

• Use of a modified Clinical Pulmonary Infection Score (CPIS)• If score is above 6, pneumonia is likely.

CPIS Points 0 1 2

Tracheal Secretions

Rare Abundant Abundant & Purulent

CXR Infiltrates No Infiltrate Diffused Localized

Temperature (ºC) > 36.5 and < 38.4 > 38.5 and < 38.9 > 39 or < 36

Leukocytes per mm3

> 4000 and

< 11,000

< 4000 or

> 11,000

< 4000 or > 11,000 with bands > 500

PF Ratio > 240 or ARDS < 240 and no evidence of ARDS

Microbiology Negative Positive

Page 11: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Bacterial Etiology – Gram +• Streptococcal (Pneumococcal)

Pneumonia• Most common (80%)• 80 different types• Pneumococcal Vaccine

• Staphylococcal Pneumonia• Staphylococcal aureus

• Primary causative agent• Methicillin-resistant (MRSA)

• Staphylococcal epidermidis • Normal flora

Page 12: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Bacterial Etiology – Gram -• Rare in “healthy” hosts

• Klebsiella pneumoniae (Friedlander’s Bacillus)

• Lobar Pneumonia• Older men and alcoholics

• Pseudomonas aeruginosa• Chronically ill, tracheotomized patients

• Haemophilus influenzae• Second most common community acquired

pneumonia (CAP) to Streptococcus pneumoniae• Secondary to viral infection• Type B is pathogenic

• HIB vaccine has reduced incidence

Page 13: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Bacterial Etiology – Gram -• Legionella pneumonphila

• American Legion in 1976• 30+ species

• Escherichia coli• GI tract normal flora

• Enterobacter sp.• Enterococcus sp.

• Normal flora in GI tract• Vancomycin Resistant Enterococcus (VRE)

• Proteus sp.• Serratia marcesens

Page 14: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Antibiotic Resistant Respiratory Bacterial

Pathogens

• Methacillian Resistant Staphylococcus Aureus (MRSA)• Treated with Vanomycin

• Vancomycin Resistant Enterococcus (VRE)• Normally found in GI tract• Nearly impossible to treat• Treated with teicoplanin & Synercid

Page 15: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Viral Pneumonia

• 90% of acute upper respiratory tract infections are caused by viruses.

• 50% of lower respiratory tract infections are due to viruses.

Page 16: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Types of Viral Pneumonias

• Influenza Virus• Types A and B are the most common• Winter months

• Respiratory Syncytial Virus (RSV)• Bronchiolitis in infants & pneumonias in elderly

• Parainfluenza Viruses• 5 types

• Type 1, 2, 3, 4A and 4B

• Type 1 is associated with croup infections

• Adenovirus

Page 17: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Types of Viral Pneumonias

• Varicella• Chickenpox & pneumonia

• Rubella• German Measles & pneumonia

• Rubeola• Measles

• Cytomegalovirus (CMV)• Member of the herpes virus• Usually seen in AIDS patients

Page 18: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Other Causes of Pneumonia• Mycoplasma Pneumoniae (Primary Atypical

Pneumonia)• Walking Pneumonia• Young (5 to 35 years of age)

• Rickettsiae• Rocky Mountain Fever, Typhus, Q fever• Transmitted by fleas, ticks, mites

• Chlamydia Psittaci (Psittacosis)• Found in respiratory tract and feces of a variety of

birds• Parrots, parakeets, cockatoos, chickens, pigeons

• Transmitted to humans via aerosol or direct contact• Chlamydia Pneumoniae

Page 19: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Other Causes of Pneumonia

•Pneumocystis carinii

•Opportunistic, often fatal, form of pneumonia seen in immunocompromised patients.

•Has been thought to be a protozoa but more recently, information suggests a fungus.

•Major cause of pneumonia in AIDS patients.

Page 20: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Fungal Infections

• AIDS patients and patients on steroids • Histoplasma capsulatum• Coccidioides immitis• Blastomyces dermatitidis• Candida albicans

• Oral thrush

• Aspergillus

• Treatment• Amphotericin B (IV)• Nystatin• Fluconazole

Page 21: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

• Aspergilloma

Page 22: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Tuberculosis• One of the oldest diseases – 4,000 B.C.• 1.5 Billion cases worldwide

• 15 million of these are active

• TB is still prevalent in US• 15,000 cases/year – 50% occur in patients born

outside the US• Highest incidence in SE US, inner cities, homeless &

jails

• HIV infection is the greatest single medical risk factor (no defense mechanism)

• Age has traditionally been considered an independent risk factor (greater chance of exposure)

Page 23: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Tuberculosis• Chronic disease requiring months of treatment.

• Suboptimal treatment can result in drug-resistant TB.• TB can affect many organs in the body but most

common location is the lungs.• Brain Kidneys• Bones Genital tract

• TB is caused by mycobacterium tuberculosis.• Produces a tubercle (lesion) that undergoes caseation.• Highly aerobic & like to grow in areas with high oxygen

tension• Brain, lung apex

• TB has airborneairborne mode of transmission• Transmitted within aerosol droplets from cough/sneeze

& can remain suspended in the air for several hours

Page 24: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Tuberculosis• Initial infection results in no sickness, no

symptoms, and the individual is not contagious (Latent TB).

• Active TB occurs with immunosuppression.• AIDS, Young, Old, Cancer, substance abuse

• Treatment is multiple first line drug therapy for 6 or 9 months

• There is an emergence of drug resistant strains of TB (MDR-TB)• Cure rate is poor

Page 25: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Categories of Tuberculosis

• Primary TB

• Post-primary TB

• Disseminated TB

Page 26: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Primary TB

• First exposure to the pathogen• Bacilli implant in the alveoli & multiply over 3-4

weeks• Inflammatory reaction

• Leukocytes, macrophages move into the area to engulf (but not kill) the bacilli

• Alveolar Consolidation

• Positive TB reaction• WBC normal

Page 27: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

TB Bacilli & Macrophages

Neutrophils

Fibroblasts Lymphocytes

Protective Cell Wall

Tubercle or granuloma

2-10 weeks

Page 28: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

•Necrosis•Cottage Cheese

•Caseation

Caseous Lesion

Page 29: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Healing

•Fibrosis

•Calcification

•Retraction of lung tissue

Page 30: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Post-primary Tuberculosis

• Reactivation of the tuberculosis months or years after the initial infection

• Most patients recover completely but the live tubercle bacilli can remain dormant for decades• May reactivate in patients with weakened

immunity

• Positive TB test• Cavity formation and possible rupture

Page 31: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Disseminated Tuberculosis

• Bacilli escape from the tubercle and rapidly disseminate to other parts of the lung or other organs• Move via the lymphatics or bloodstream

• Miliary Tuberculosis• Small tubercles scattered throughout the body

via blood stream.

Page 32: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)
Page 33: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Symptoms

• General malaise• Cough with sputum production

• Minimal initially, gradually increasing

• Night sweats• Chills• Increasing dyspnea• Chest pain• Loss of appetite• Weight loss

CONSUMPTION

Page 34: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Chest x-ray

• Initial Lung Lesion is called a Ghon nodule

• Ghon nodule + involvement of lymph nodes in the hilar region is the Ghon Complex

• Multiple Nodules (supra- or retroclavicular)

• Pleural Effusions

• Cavity Formation

Page 35: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Diagnostic Testing• TB skin test

• Mantoux Test • 5 of purified protein derivative (PPD) in 0.1 mL of

solution is injected.• Induration of 10 mm or greater is positive test

• Sputum Cultures and Acid fast stain• Ziehl-Neelsen & Fluorescent Stain• Culture will differentiate M. Tuberculosis from other

acid fast organisms (6-8 weeks)• Sputum may show AFB but negative for TB

• Chest x-rays

Page 36: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Drug Therapy for Tuberculosis• First Line

• R – rifampin (Rimactane) (*)• I – isoniazid (INH) (+)• P – pyrazinamide (Tebrazid)• E – ethambutol (Myambutol) • R – rifapentine (Priftin) (*)• R – rifabutin (Mycobutin)

• Use if patient receiving antiretroviral

• Second Line• Streptomycin

• (*) Reduces efficacy of oral contraceptives.• (+) Liver toxicity when alcohol is used.

Page 37: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Treatment

• If a patient does not respond to treatment in 2-3 weeks, suspect:• Non-compliance with drug regimen• Multiple drug resistant organisms (MDR-TB)

• Oxygen

Page 38: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Prophylactic Treatment

• Isoniazid if often prescribed as a daily dose for one year in individuals exposed to TB• Positive TB skin Test

Page 39: INFECTIOUS PULMONARY DISEASES Module H Pneumonia -Chapter 15 (pp. 224-241) Lung Abscess - Chapter 16 (pp. 242-249) Tuberculosis – Chapter 17 (pp. 250-259)

Safety Precautions

• Isolation• Keep door closed

• National Institute for Occupational Safety and Health (NIOSH) recommends particulate filter respirators for HCWs• Surgical masks are not very effective against

TB